Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / SPONSORED ADS
-
Total 13F shares
-
4,724,797
-
Share change
-
-119,944
-
Total reported value
-
$11,905,892
-
Put/Call ratio
-
65%
-
Price per share
-
$2.52
-
Number of holders
-
44
-
Value change
-
-$346,454
-
Number of buys
-
16
-
Number of sells
-
23
Institutional Holders of REDHILL BIOPHARMA LTD - SPONSORED ADS (RDHL) as of Q1 2022
As of 31 Mar 2022,
REDHILL BIOPHARMA LTD - SPONSORED ADS (RDHL) was held by
44 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,724,797 shares.
The largest 10 holders included
DISCIPLINED GROWTH INVESTORS INC /MN, ARK Investment Management LLC, GAGNON SECURITIES LLC, BlackRock Inc., CLARET ASSET MANAGEMENT Corp, Ancora Advisors, LLC, BARCLAYS PLC, Candriam Luxembourg S.C.A., Creative Planning, and CIBC WORLD MARKET INC..
This page lists
44
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.